UNIDRIVE Select System
Karl Storz SE & CO. KG · Decision date Sep 1, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision on September 1, 2026 for the UNIDRIVE Select System, a 510(k) submitted by Karl Storz SE & CO. KG under number K260884. The application was received March 17, 2026, and the device is classified as a laparoscope for general and plastic surgery under regulation 876.1500, product code GCJ, within the Gastroenterology/Urology review panel. SESE denotes clearance to market, not premarket approval.
The FDA document describes the UNIDRIVE Select System as a motorized surgical system operated with software license UM604. The available excerpts also reference an AC powered battery charger, suction tube and suction canister, but do not establish which of these are the changed or added items, nor the specific predicate device or the scope of any comparison. Indications, clinical performance data and labeling details are not present in the retrieved text and remain unknown from this source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Sep 1, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260884
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Karl Storz SE & CO. KG
- Product code
- GCJ
- Decision code
- SESE
- Decision date
- Sep 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Laparoscope, General & Plastic Surgery.
- Applicant
- Karl Storz SE & CO. KG
- Product code
- GCJ
- FDA device class
- 2
FDA decision timeline
K260884 received
Application receipt date recorded by FDA.
K260884 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GCJ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
SWICSK263459 | Bloom Surgical, Inc. | 510(k) clearance | Oct 29, 2026 | FDA |
| Intuitive Surgical, Inc. | 510(k) clearance | Oct 14, 2026 | FDA | |
CuratOR EX2742K262397 | Eizo Corporation | 510(k) clearance | Sep 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Karl Storz SE & CO. KG
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Tuttlingen
Sources and methodology
- Original FDA record: K260884
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

